BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10603101)

  • 1. Liver transplantation in maple syrup urine disease.
    Wendel U; Saudubray JM; Bodner A; Schadewaldt P
    Eur J Pediatr; 1999 Dec; 158 Suppl 2():S60-4. PubMed ID: 10603101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Living related versus deceased donor liver transplantation for maple syrup urine disease.
    Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA
    Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of branched-chain amino acids in maple syrup urine disease.
    Schadewaldt P; Wendel U
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S62-6. PubMed ID: 9266218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation.
    Deon M; Guerreiro G; Girardi J; Ribas G; Vargas CR
    Int J Dev Neurosci; 2023 Oct; 83(6):489-504. PubMed ID: 37340513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA; Carson VJ; Soltys K; Young ME; Bowser LE; Puffenberger EG; Brigatti KW; Williams KB; Robinson DL; Hendrickson C; Beiler K; Taylor CM; Haas-Givler B; Chopko S; Hailey J; Muelly ER; Shellmer DA; Radcliff Z; Rodrigues A; Loeven K; Heaps AD; Mazariegos GV; Morton DH
    Mol Genet Metab; 2020 Mar; 129(3):193-206. PubMed ID: 31980395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous liver transplantation for maple syrup urine disease: First European reported case.
    Roilides I; Xinias I; Mavroudi A; Ioannou H; Savopoulou P; Imvrios G
    Pediatr Transplant; 2016 Sep; 20(6):846-50. PubMed ID: 27357264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease.
    Schadewaldt P; Hammen HW; Ott AC; Wendel U
    J Inherit Metab Dis; 1999 Aug; 22(6):706-22. PubMed ID: 10472531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domino liver transplantation in maple syrup urine disease: a case report and review of the literature.
    Badell IR; Hanish SI; Hughes CB; Hewitt WR; Chung RT; Spivey JR; Knechtle SJ
    Transplant Proc; 2013 Mar; 45(2):806-9. PubMed ID: 23267808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living donor liver transplantation in maple syrup urine disease - Case series and world's youngest domino liver donor and recipient.
    Mohan N; Karkra S; Rastogi A; Vohra V; Soin AS
    Pediatr Transplant; 2016 May; 20(3):395-400. PubMed ID: 26869348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease.
    Heindel W; Kugel H; Wendel U; Roth B; Benz-Bohm G
    Pediatr Radiol; 1995; 25(4):296-9. PubMed ID: 7567243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
    Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
    Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Domino liver transplantation in maple syrup urine disease.
    Khanna A; Hart M; Nyhan WL; Hassanein T; Panyard-Davis J; Barshop BA
    Liver Transpl; 2006 May; 12(5):876-82. PubMed ID: 16628687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful domino liver transplantation in maple syrup urine disease using a related living donor.
    Feier FH; Miura IK; Fonseca EA; Porta G; Pugliese R; Porta A; Schwartz IV; Margutti AV; Camelo JS; Yamaguchi SN; Taveira AT; Candido H; Benavides M; Danesi V; Guimaraes T; Kondo M; Chapchap P; Neto JS
    Braz J Med Biol Res; 2014 Jun; 47(6):522-6. PubMed ID: 24770567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
    Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
    Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
    Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
    J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of liver transplantation for maple syrup urine disease: A single-center experience in Turkey.
    Aras A; Avanaz A; Inan Aydemir N; Kayaalp E; Ulgen Tekerek N; Kisaoglu A; Demiryilmaz I; Soyucen E; Dursun O; Yilmaz A; Artan R; Aydinli B
    Pediatr Transplant; 2023 May; 27(3):e14464. PubMed ID: 36588190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
    Thompson GN; Francis DE; Halliday D
    J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein and lipid damage in maple syrup urine disease patients: l-carnitine effect.
    Mescka CP; Wayhs CA; Vanzin CS; Biancini GB; Guerreiro G; Manfredini V; Souza C; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2013 Feb; 31(1):21-4. PubMed ID: 23137711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.